-
ABPI Website
- International, trade and IP
International, trade and IP
International research
To address the major health challenges of our time, the global pharmaceutical sector is pioneering cutting-edge science that can help develop new treatments and cures for diseases from cancer to dementia, as well as preventing disease through the latest generation of vaccines.
Intellectual property (IP)
The fundamental role of IP for protecting and promoting UK scientific innovation and securing the UK’s ambition to be a life science super power
International trade
The UK’s international trading relationships with existing and future partners is fundamental to the continued success of the life sciences and sustainable, resilient supply of medicines for the NHS.
International regulation
The UK is part of an increasingly competitive and changing global ecosystem. Regulatory regimes need to be dynamic and constantly evolving to adapt to the latest scientific and technological advances, as well as factors such as environmental sustainability and data privacy.
International, trade and IP publications
-
Facilitating trade in health products through international manufacturing recognition and harmonisation policy
The UK can bolster its position as a leader in life sciences by charting a pragmatic approach towards, and engaging purposefully with, a global recognition policy for manufacturing.
-
Building the UK’s international research collaborations
International research collaborations are fundamental to the discovery and early development of new medicines and vaccines.
-
WTO Twelfth Ministerial Conference: A Critical Opportunity to Strengthen the Global Trade and Health Agenda
The WTO’s Twelfth Ministerial Conference (MC12) presents an opportunity for WTO members to formalize and pursue a robust trade and health agenda that builds on these principles and further strengthens the open and rules-based international trading system in response to COVID-19 and future health crises.